To determine whether COL10A1 expression levels were associated with specific genomic characteristics in BLCA, we performed somatic mutation analysis based on COL10A1 expression levels by using the “maftools” package in the TCGA-BLCA database, in which the top 20 mutational genes were displayed. This evidence concerns the gene COL10A1 and bladder transitional cell carcinoma.